*

Maven raises $125 mln in Series F round

*

Funding round led by investment firm StepStone

*

Maven's total funding climbs over $425 mln

Oct 8 (Reuters) - Health firm Maven Clinic said on

Tuesday it had raised $125 million in its latest funding round

led by private markets investment firm StepStone Group ( STEP ).

The funding round also included participation from Maven's

existing investors General Catalyst, Sequoia, Oak HC/FT, Icon

Ventures, Dragoneer Investment Group and Lux Capital.

Hopes of a soft landing for the economy and the U.S. Federal

Reserve going ahead with a long-awaited rate cut has encouraged

investors to pour more funds into startups.

The latest financing round brings Maven's total funding to

more than $425 million, the company said. Maven had last raised

$90 million in a Series E funding round in 2022 led by General

Catalyst.

Founded in 2014 by CEO Kate Ryder, Maven partners with

employers and health plans to provide clinical support through

its platform on preconception, family building, pregnancy,

parenting and menopause.

The New York-based firm caters to more than 2,000 customers

in 175 countries including telecom operator AT&T ( T ), Wall

Street giant Morgan Stanley ( MS ), and French cosmetics giant

L'Oreal.

Maven will use the proceeds to further invest in Maven

Managed Benefit, its fertility benefits administration platform.

Additionally, the company will also use the funds to bolster

its offerings across both fully insured and Medicaid

populations.